Entries by Advanced Laparoscopic

How Much Weight Will You Regain After You Stop Injecting Weight-Loss Drugs?

A recent study on the effects of stopping tirzepatide (Monjauro / Zepbound), reveals that individuals who stopped tirzepatide experienced substantial weight regain (approximately 14%), highlighting the challenges associated with relying on such medications for long-term results. Dr. Alexander Abkin, a leading bariatric surgeon in New Jersey, emphasizes the limitations of injectable weight-loss drugs as a […]

Dr. Abkin Voted “Top Doc” in Bariatric Surgery by NJ Monthly Magazine for 17th Consecutive Year

Dr. Alexander Abkin, renowned bariatric surgeon and director of bariatric surgery at Saint Clare’s Health System (Dover) and HMH JFK University Medical Center (Edison), has once again been recognized by his peers as a “Top Doc” in the field of bariatric surgery by New Jersey Monthly Magazine. This prestigious award marks the 17th consecutive year […]

How Remote Work Might Add 800 Calories to Your Day and Why Weight Loss Surgery Can Help

The advent of remote work has revolutionized the way we conduct business, offering flexibility and convenience like never before. However, this shift to working from home has also brought about some unexpected challenges, one of which is the potential for significant weight gain. Surprisingly, many remote workers find themselves consuming an additional 800 calories and […]

Bariatric Procedure Outperforms Semaglutide in Patients With Obesity, Fatty Liver

A recent study was published comparing two treatments for people with obesity and a liver condition called metabolic dysfunction-associated steatotic liver disease (MASLD). The two treatments tested were bariatric surgery and a medication called semaglutide. The findings showed that bariatric surgery led to more weight loss and better improvements in liver health compared to semaglutide. […]

FDA Adds Intestinal Blockage as Potential Side Effect to Ozempic, Wegovy

The U.S. Food and Drug Administration (FDA) has recently made a significant update to the label of Ozempic, a medication commonly prescribed for type 2 diabetes and increasingly used for weight loss. This update highlights a potential side effect that patients and healthcare providers should be aware of – intestinal blockage.  Another weight loss drug […]